Luther King Capital Management (LKCM)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$179M Sell
510,096
-5,572
-1% -$1.99M 0.78% 37
2025
Q4
$169M Buy
515,668
+6,510
+1% +$2.07M 0.69% 40
2025
Q3
$144M Buy
509,158
+1,653
+0.3% +$479K 0.59% 46
2025
Q2
$142M Sell
507,505
-6,577
-1% -$1.86M 0.62% 44
2025
Q1
$160M Sell
514,082
-5,522
-1% -$1.63M 0.74% 40
2024
Q4
$135M Buy
519,604
+1,637
+0.3% +$486K 0.59% 47
2024
Q3
$167M Buy
517,967
+6,587
+1% +$2.15M 0.72% 42
2024
Q2
$160M Sell
511,380
-539
-0.1% -$158K 0.72% 41
2024
Q1
$146M Sell
511,919
-13,750
-3% -$4.02M 0.66% 47
2023
Q4
$151M Buy
525,669
+2,466
+0.5% +$672K 0.73% 39
2023
Q3
$141M Buy
523,203
+572
+0.1% +$143K 0.73% 42
2023
Q2
$116M Sell
522,631
-14,990
-3% -$3.48M 0.58% 52
2023
Q1
$130M Sell
537,621
-2,180
-0.4% -$535K 0.69% 44
2022
Q4
$142M Sell
539,801
-1,753
-0.3% -$470K 0.78% 42
2022
Q3
$122M Sell
541,554
-4,157
-0.8% -$1.01M 0.73% 43
2022
Q2
$133M Sell
545,711
-2,298
-0.4% -$563K 0.74% 42
2022
Q1
$133M Sell
548,009
-544
-0.1% -$125K 0.65% 45
2021
Q4
$123M Sell
548,553
-4,578
-0.8% -$966K 0.56% 56
2021
Q3
$118M Sell
553,131
-18,068
-3% -$4.16M 0.58% 54
2021
Q2
$139M Sell
571,199
-11,022
-2% -$2.71M 0.68% 48
2021
Q1
$145M Sell
582,221
-6,755
-1% -$1.61M 0.78% 40
2020
Q4
$135M Sell
588,976
-10,352
-2% -$2.39M 0.76% 41
2020
Q3
$152M Sell
599,328
-3,280
-0.5% -$813K 0.96% 34
2020
Q2
$142M Buy
602,608
+1,185
+0.2% +$270K 0.99% 32
2020
Q1
$122M Sell
601,423
-11,128
-2% -$2.43M 1.06% 32
2019
Q4
$148M Sell
612,551
-1,762
-0.3% -$388K 0.99% 38
2019
Q3
$119M Sell
614,313
-12,999
-2% -$2.5M 0.86% 41
2019
Q2
$116M Sell
627,312
-3,973
-0.6% -$711K 0.84% 43
2019
Q1
$120M Buy
631,285
+13,017
+2% +$2.49M 0.92% 43
2018
Q4
$120M Buy
618,268
+10,976
+2% +$2.14M 1.07% 35
2018
Q3
$126M Sell
607,292
-1,340
-0.2% -$264K 0.95% 36
2018
Q2
$112M Sell
608,632
-5,022
-0.8% -$888K 0.92% 39
2018
Q1
$105M Buy
613,654
+12,195
+2% +$2.24M 0.88% 43
2017
Q4
$105M Buy
601,459
+20
+0% +$3.54K 0.86% 44
2017
Q3
$112M Sell
601,439
-7,669
-1% -$1.36M 0.98% 38
2017
Q2
$105M Sell
609,108
-21,713
-3% -$3.53M 0.95% 41
2017
Q1
$103M Buy
630,821
+2,841
+0.5% +$472K 0.95% 39
2016
Q4
$91.8M Buy
627,980
+22,462
+4% +$3.38M 0.87% 43
2016
Q3
$101M Buy
605,518
+45,103
+8% +$7.63M 0.99% 36
2016
Q2
$85.3M Buy
560,415
+23,550
+4% +$3.66M 0.83% 45
2016
Q1
$80.5M Sell
536,865
-12,089
-2% -$1.8M 0.8% 49
2015
Q4
$89.1M Buy
548,954
+14,891
+3% +$2.34M 0.84% 42
2015
Q3
$73.9M Sell
534,063
-16,930
-3% -$2.67M 0.72% 46
2015
Q2
$84.6M Buy
550,993
+255
+0% +$40.8K 0.73% 50
2015
Q1
$88M Sell
550,738
-66
-0% -$10.4K 0.74% 48
2014
Q4
$87.7M Buy
550,804
+1,980
+0.4% +$309K 0.71% 48
2014
Q3
$77.1M Buy
548,824
+8,893
+2% +$1.16M 0.63% 54
2014
Q2
$63.9M Buy
539,931
+11,149
+2% +$1.29M 0.51% 63
2014
Q1
$65.2M Buy
528,782
+29,011
+6% +$3.52M 0.53% 58
2013
Q4
$57M Sell
499,771
-16,039
-3% -$1.82M 0.46% 70
2013
Q3
$57.7M Buy
515,810
+67,939
+15% +$7.37M 0.5% 62
2013
Q2
$44.2M Buy
+447,871
New +$46.5M 0.41% 76

Other funds holding AMGN

Luther King Capital Management (LKCM)'s AMGN Position: Q1 2026 in Review

Luther King Capital Management (LKCM) reduced its Amgen (AMGN) stake by 1.1% in Q1 2026, selling an estimated $1.99M and leaving 510,096 shares worth $179M. The position accounts for 0.78% of the portfolio, ranked #37.

Luther King Capital Management (LKCM) first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Luther King Capital Management (LKCM) held 510,096 shares of Amgen worth $179M as of Q1 2026.
  • Luther King Capital Management (LKCM) sold 5,572 Amgen shares in Q1 2026, an estimated $1.99M.
  • Amgen made up 0.78% of Luther King Capital Management (LKCM)'s portfolio in Q1 2026, its #37 holding.
  • Luther King Capital Management (LKCM) first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q1 2026, filed 11 May 2026.